ENERZAIR

This brand name is authorized in Australia, Austria, Canada, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, South Africa, UK.

Active ingredients

The drug ENERZAIR contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII RYI4401DTM - INDACATEROL ACETATE
 

Indacaterol is a partial agonist at the human beta2-adrenergic receptor with nanomolar potency. When inhaled, indacaterol acts locally in the lung as a bronchodilator. In isolated human bronchus, indacaterol has a rapid onset of action and a long duration of action.

 
Read more about Indacaterol
2
UNII V92SO9WP2I - GLYCOPYRROLATE
 

Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways.

 
Read more about Glycopyrronium
3
UNII 04201GDN4R - MOMETASONE FUROATE
 

Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade.

 
Read more about Mometasone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R03AL12 R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics
Discover more medicines within R03AL12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 12295D, 12298G
CA Health Products and Food Branch 02501244
EE Ravimiamet 1822014, 1822025, 1822036, 1822047, 1822058
FI Lääkealan turvallisuus- ja kehittämiskeskus 398265, 498726, 580713
FR Base de données publique des médicaments 61300756
GB Medicines & Healthcare Products Regulatory Agency 391348, 391349
HK Department of Health Drug Office 67209
IE Health Products Regulatory Authority 42807, 42808
IL מִשְׂרַד הַבְּרִיאוּת 9012
IT Agenzia del Farmaco 048913014, 048913026, 048913038, 048913040, 048913053
JP 医薬品医療機器総合機構 2290807G1026, 2290807G2022
LT Valstybinė vaistų kontrolės tarnyba 1090760, 1090761, 1090762, 1090763, 1090764
NL Z-Index G-Standaard, PRK 205125
PL Rejestru Produktów Leczniczych 100440115
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W66830001, W66830002, W66830003, W66830004, W66830005
ZA Health Products Regulatory Authority 54/10.2.1/0873, 54/10.2.1/0874

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.